| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |